Press releases
- Protalix BioTherapeutics to Present at the 2024 BIO International Convention
- Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results
- Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024
- Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
Key statistics
As of last trade Protalix Biotherapeutics Inc (PBDA:MUN) traded at 1.08, 3.89% above its 52-week low of 1.04, set on May 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.08 |
---|---|
High | 1.08 |
Low | 1.08 |
Bid | 1.06 |
Offer | 1.11 |
Previous close | 1.06 |
Average volume | 0.00 |
---|---|
Shares outstanding | 73.32m |
Free float | 62.63m |
P/E (TTM) | 18.46 |
Market cap | 82.11m USD |
EPS (TTM) | 0.0607 USD |
Data delayed at least 15 minutes, as of Jun 11 2024 07:02 BST.
More ▼